IHS Chemical Week

Regions :: China

Evonik API site in China receives written confirmation of EU GMP compliance

11:24 AM MDT | October 28, 2013 | Deepti Ramesh

Evonik Industries says that it was one of the first active pharmaceutical ingredient (API)–producing companies in China to be granted written confirmations by the Guangxi Food and Drug Administration for all products manufactured at the company's site at Wuming, China. These confirmations certify that the facility operates in accordance with EU GMP requirements. As of 2 July, the compliance of APIs manufactured outside and imported into the EU must be confirmed in writing by a competent authority of the exporting country. This document must also...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa